Status:
COMPLETED
Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina
Lead Sponsor:
Hospital Italiano de Buenos Aires
Collaborating Sponsors:
Hospital de Niños R. Gutierrez de Buenos Aires
Salud Comunitaria Ministerio de Salud GCBA
Conditions:
SARS-CoV-2
Eligibility:
All Genders
14+ years
Brief Summary
Background The study aimed to establish the seroprevalence of SARS-COV-2 in an Argentinian slum three months after the first case was reported. Methods Between June 10th and July 1st, a cross-section...
Detailed Description
A community-level seroprevalence survey was conducted in a cross-sectional design during a Participatory Action Research (PAR). Starter PAR team: researcher who developed the Elisa Test, virologist t...
Eligibility Criteria
Inclusion
- All subjects of 14 years or more who accept to be test
Exclusion
- none
Key Trial Info
Start Date :
June 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 11 2020
Estimated Enrollment :
873 Patients enrolled
Trial Details
Trial ID
NCT04472078
Start Date
June 10 2020
End Date
December 11 2020
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Niños Ricardo Gutierrez
Buenos Aires, Buenos Aires F.D., Argentina, 1425